Enovis Announces First Quarter 2023 Results
May 04, 2023 06:00 ET
|
Enovis Corporation
Strong start to the year with sales growth of 8%, organic growth of 9% and strong EBITDA margin expansionOrganic growth of 9% reflects 19% organic growth in Recon and 4% organic growth in...
Enovis to Host First Quarter 2023 Results Conference Call on May 4th
April 13, 2023 12:21 ET
|
Enovis Corporation
Wilmington, DE, April 13, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call...
Enovis to Acquire Novastep
April 03, 2023 07:00 ET
|
Enovis Corporation
Wilmington, DE, April 03, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced a definitive agreement to acquire...
Enovis Announces Board Leadership Transition
March 15, 2023 16:30 ET
|
Enovis Corporation
Wilmington, DE, March 15, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that CEO Matt Trerotola will assume the...
ENOVIS™ Showcases Next Generation of Medical Technology at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting
March 03, 2023 10:35 ET
|
Enovis Corporation
Wilmington, DE, March 03, 2023 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced that it will feature its next generation of medical...
Newsweek Names Enovis™ as One of America’s Greatest Workplaces for Diversity 2023
February 27, 2023 08:00 ET
|
Enovis Corporation
Wilmington, DE, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced that it has been recognized as one of America’s...
Enovis Announces Fourth Quarter and Full Year 2022 Results
February 23, 2023 06:00 ET
|
Enovis Corporation
Wilmington, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced its financial results for the...
Enovis to Host Fourth Quarter and Full Year 2022 Conference Call on February 23rd
February 10, 2023 15:45 ET
|
Enovis Corporation
Wilmington, DE, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference...
Enovis™ to Showcase Latest Innovations and Growing Foot & Ankle Portfolio at ACFAS 2023
February 08, 2023 06:00 ET
|
Enovis Corporation
Wilmington, DE, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced it will showcase its growing Foot & Ankle...
Enovis Expands Foot & Ankle Portfolio’s DynaClip® Family by Introducing Procedure-Specific Staples
January 17, 2023 09:00 ET
|
Enovis Corporation
Wilmington, DE, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced the launch of the DynaClip Delta™ and DynaClip...